Skip to main content
. 2021 Jun 4;11:694594. doi: 10.3389/fonc.2021.694594

Figure 2.

Figure 2

The lower expression of BDH1 predicts the worse prognosis for AML patients. (A, B) Shown are comparisons of BDH1 gene expression levels among AML patients of different cytogenetic-risk classifications in TCGA-LAML database (A) and GSE6891 database (B), and comparison of BDH1 gene expression among AML patients of different FAB subtypes in TCGA-LAML database (C) and GSE6891 database (D). The expression values were log2-transformed and mean centered. The P values were detected by t-test. (E, F) Kaplan-Meier survival curves of BDH1 in TCGA-LAML (left) (E) and GSE6891 (right) (F) database. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.